Chemoinformaics analysis of P-HYDROXYBANZOIC-ACID
| Molecular Weight | 152.149 | nRot | 1 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 7 |
| Exact Molecular Weight | 152.047 | nRing | 1 |
| Solubility: LogS | -1.861 | nHRing | 0 |
| Solubility: LogP | 1.84 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 21.1003 |
| nHD | 1 | BPOL | 10.6297 |
| QED | 0.614 |
| Synth | 1.387 |
| Natural Product Likeliness | 0.233 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.418 |
| MDCK | 0.0000204 |
| BBB | 0.569 |
| PPB | 0.822342 |
| VDSS | 0.731 |
| FU | 0.157989 |
| CYP1A2-inh | 0.938 |
| CYP1A2-sub | 0.771 |
| CYP2c19-inh | 0.616 |
| CYP2c19-sub | 0.135 |
| CYP2c9-inh | 0.173 |
| CYP2c9-sub | 0.912 |
| CYP2d6-inh | 0.122 |
| CYP2d6-sub | 0.691 |
| CYP3a4-inh | 0.076 |
| CYP3a4-sub | 0.236 |
| CL | 13.9 |
| T12 | 0.905 |
| hERG | 0.056 |
| Ames | 0.018 |
| ROA | 0.095 |
| SkinSen | 0.307 |
| Carcinogencity | 0.162 |
| EI | 0.989 |
| Respiratory | 0.091 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.852355 |